Literature DB >> 6713204

Pain-induced vocalization in the rat and its modification by pharmacological agents.

J D Levine, M Feldmesser, L Tecott, N C Gordon, K Izdebski.   

Abstract

Vocalization was induced in rats by electrical stimulation of the tail (pain-induced vocalization), and its components were characterized in terms of latency, duration, frequency spectrum and energy. Noxious stimuli at threshold elicit a single vocalization component (V1). Increases in stimulus intensity produce additional discrete vocalization components (V2-Vn) with successively longer latencies, termed the vocalization afterdischarge (AD). The AD components are acoustically similar to each other but differ significantly from the V1 component. The duration, the specific acoustic measures and the sound energy of both V1 and AD components are positively correlated with intensity of the stimulus. The dependence of the V1 and AD components on the affective state of the rat was evaluated by comparing the acoustic characteristics of both components to those of stress-induced vocalizations, and by studying the effects of the anxiolytic drug diazepam and physical restraint on the threshold of V1 and AD. The AD components were markedly more dependent on the affective state of the rat then was the V1 component. A moderately low dose of morphine (3.0 mg/kg) also preferentially affected the AD component, suggesting that a significant portion of the action of morphine on pain-induced vocalization is mediated through its action on the affective state of the rat.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6713204     DOI: 10.1016/0006-8993(84)90517-1

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  10 in total

1.  Chronic opioids impair acquisition of both radial maze and Y-maze choice escape.

Authors:  J W Spain; G C Newsom
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

2.  Developing Improved Translational Models of Pain: A Role for the Behavioral Scientist.

Authors:  Sarah L Withey; David R Maguire; Brian D Kangas
Journal:  Perspect Behav Sci       Date:  2020-01-03

3.  Female- and Intruder-induced Ultrasonic Vocalizations in C57BL/6J Mice as Proxy Indicators for Animal Wellbeing.

Authors:  Brian J Smith; Kate E P Bruner; Lon V Kendall
Journal:  Comp Med       Date:  2019-10-02       Impact factor: 0.982

Review 4.  Aggression, anxiety and vocalizations in animals: GABAA and 5-HT anxiolytics.

Authors:  K A Miczek; E M Weerts; J A Vivian; H M Barros
Journal:  Psychopharmacology (Berl)       Date:  1995-09       Impact factor: 4.530

5.  Effects of morphine, naloxone and their interaction in the learned-helplessness paradigm in rats.

Authors:  A Besson; A M Privat; A Eschalier; J Fialip
Journal:  Psychopharmacology (Berl)       Date:  1996-01       Impact factor: 4.530

6.  Morphine attenuates ultrasonic vocalization during agonistic encounters in adult male rats.

Authors:  J A Vivian; K A Miczek
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

7.  Acute immobilization stress reduces (+/-)DOI-induced 5-HT2A receptor-mediated head shakes in rats.

Authors:  S Yamada; A Watanabe; M Nankai; M Toru
Journal:  Psychopharmacology (Berl)       Date:  1995-05       Impact factor: 4.530

8.  Predictability and heritability of individual differences in fear learning.

Authors:  Jason Shumake; Sergio Furgeson-Moreira; Marie H Monfils
Journal:  Anim Cogn       Date:  2014-05-05       Impact factor: 3.084

9.  Mice Lacking Serotonin 2C Receptors Have increased Affective Responses to Aversive Stimuli.

Authors:  Stephen J Bonasera; A Katrin Schenk; Evan J Luxenberg; Xidao Wang; Allan Basbaum; Laurence H Tecott
Journal:  PLoS One       Date:  2015-12-02       Impact factor: 3.240

10.  Pharmacological validation of a novel nonhuman primate measure of thermal responsivity with utility for predicting analgesic effects.

Authors:  Joshua D Vardigan; Andrea K Houghton; Henry S Lange; Emily D Adarayan; Parul S Pall; Jeanine E Ballard; Darrell A Henze; Jason M Uslaner
Journal:  J Pain Res       Date:  2018-04-11       Impact factor: 3.133

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.